166 related articles for article (PubMed ID: 1649896)
21. T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
[TBL] [Abstract][Full Text] [Related]
22. Characterization of Epstein-Barr virus Type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes.
Görzer I; Niesters HG; Cornelissen JJ; Puchhammer-Stöckl E
Virus Res; 2006 Jun; 118(1-2):105-14. PubMed ID: 16406167
[TBL] [Abstract][Full Text] [Related]
23. Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): predominance of type A virus associated with Hodgkin's disease.
Lin JC; Lin SC; De BK; Chan WP; Evatt BL; Chan WC
Blood; 1993 Jun; 81(12):3372-81. PubMed ID: 8389616
[TBL] [Abstract][Full Text] [Related]
24. Detection of a second widespread strain of Epstein-Barr virus.
Sixbey JW; Shirley P; Chesney PJ; Buntin DM; Resnick L
Lancet; 1989 Sep; 2(8666):761-5. PubMed ID: 2571010
[TBL] [Abstract][Full Text] [Related]
25. Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus.
Frank D; Cesarman E; Liu YF; Michler RE; Knowles DM
Blood; 1995 Mar; 85(5):1396-403. PubMed ID: 7858270
[TBL] [Abstract][Full Text] [Related]
26. Comparative sequence analyses of Epstein-Barr virus nuclear antigen-2 and -3B genes of a fresh Epstein-Barr virus-2 isolate.
Inoue N; Kikuta H; Yanagi K
Intervirology; 1992; 33(4):180-6. PubMed ID: 1339417
[TBL] [Abstract][Full Text] [Related]
27. Analysis of Epstein-Barr virus (EBV) type and variant in spontaneous lymphoblastoid cells and Hu-SCID mouse tumours.
Menin C; Ometto L; Veronesi A; Roncella S; Corneo B; Montagna M; Coppola V; Veronese ML; Indraccolo S; Amadori A; De Rossi A; Ferrarini M; Chieco-Bianchi L; D'Andrea E
Mol Cell Probes; 1996 Dec; 10(6):453-61. PubMed ID: 9025083
[TBL] [Abstract][Full Text] [Related]
28. Synthetic peptides deduced from the amino acid sequence of Epstein-Barr virus nuclear antigen 6 (EBNA 6): antigenic properties, production of monoreactive reagents, and analysis of antibody responses in man.
Falk K; Linde A; Johnson D; Lennette E; Ernberg I; Lundkvist A
J Med Virol; 1995 Aug; 46(4):349-57. PubMed ID: 7595412
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
[TBL] [Abstract][Full Text] [Related]
30. Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins.
Sample C; Parker B
Virology; 1994 Dec; 205(2):534-9. PubMed ID: 7975254
[TBL] [Abstract][Full Text] [Related]
31. Gene variations of Epstein-Barr virus nuclear antigen 3A in nasopharyngeal carcinomas, gastric carcinomas and healthy carriers in northern China.
Wang X; Wu G; Wang Y; Sun Z; Luo B
Arch Virol; 2013 Oct; 158(10):2041-8. PubMed ID: 23605669
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.
Tomkinson B; Robertson E; Kieff E
J Virol; 1993 Apr; 67(4):2014-25. PubMed ID: 8445720
[TBL] [Abstract][Full Text] [Related]
33. Excretion of the Epstein-Barr virus from the genital tract of men.
Israele V; Shirley P; Sixbey JW
J Infect Dis; 1991 Jun; 163(6):1341-3. PubMed ID: 1645383
[TBL] [Abstract][Full Text] [Related]
34. [Epstein-Barr virus-specific immunity in asymptomatic carriers of human T-cell leukemia virus type 1].
Kwon KW
Hokkaido Igaku Zasshi; 1995 Mar; 70(2):315-28. PubMed ID: 7774883
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus.
Aitken C; Sengupta SK; Aedes C; Moss DJ; Sculley TB
J Gen Virol; 1994 Jan; 75 ( Pt 1)():95-100. PubMed ID: 8113744
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus.
Rowe M; Finke J; Szigeti R; Klein G
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1217-28. PubMed ID: 2838572
[TBL] [Abstract][Full Text] [Related]
37. Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection.
Tomkinson B; Kieff E
J Virol; 1992 Feb; 66(2):780-9. PubMed ID: 1309912
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus nuclear antigen (EBNA): size polymorphism of EBNA 1.
Allday MJ; MacGillivray AJ
J Gen Virol; 1985 Jul; 66 ( Pt 7)():1595-600. PubMed ID: 2991431
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
Allday MJ; Crawford DH; Thomas JA
J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
[TBL] [Abstract][Full Text] [Related]
40. A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals.
Yao QY; Rickinson AB; Epstein MA
Int J Cancer; 1985 Jan; 35(1):35-42. PubMed ID: 2981780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
